Evidence map›Paper›PMID 32999035›Full record

ArticleJournal of virology2020

Nitish Boodhoo, Nitin Kamble, Shahriar Behboudi

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nitish BoodhooThe Pirbright Institute, Pirbright, Woking, United Kingdom.
Nitin KambleThe Pirbright Institute, Pirbright, Woking, United Kingdom.
Shahriar BehboudiThe Pirbright Institute, Pirbright, Woking, United Kingdom shahriar.behboudi@pirbright.ac.uk.ORCID 0000-0001-6455-4086
The Pirbright Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/N002598/1Biotechnology and Biological Sciences Research Council BB/S01506X/1Biotechnology and Biological Sciences Research Council BBS/E/I/00007030Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007032Biotechnology and Biological Sciences Research Council BBS/E/I/00007039
6 · The paper itself

Abstract

Marek's disease virus (MDV) transforms CD4

Indexed as

AnimalsAntigens, ViralChickensCholesterolHerpesvirus 2, GallidHomeostasisLanosterolLipid MetabolismLipogenesisLysosomal Membrane ProteinsMarek DiseaseMevalonic AcidProtein TransportTranscription FactorsViral Envelope ProteinsViral ProteinsAntigens, ViralCholesterolglycoprotein B, Marek's disease virusLanosterolLysosomal Membrane ProteinsMevalonic AcidTranscription FactorsViral Envelope ProteinsViral ProteinsMarek’s disease virus

Identifiers

PMID32999035
PMCPMC7925193
OpenAlexW3089377382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.